Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Embryonic osteocalcin signaling determines lifelong adrenal steroidogenesis and homeostasis in the mouse
Vijay K. Yadav, … , Perumal Nagarajan, Gerard Karsenty
Vijay K. Yadav, … , Perumal Nagarajan, Gerard Karsenty
Published December 14, 2021
Citation Information: J Clin Invest. 2022;132(4):e153752. https://doi.org/10.1172/JCI153752.
View: Text | PDF
Research Article Bone biology Metabolism

Embryonic osteocalcin signaling determines lifelong adrenal steroidogenesis and homeostasis in the mouse

  • Text
  • PDF
Abstract

Through their ability to regulate gene expression in most organs, glucocorticoid (GC) hormones influence numerous physiological processes and are therefore key regulators of organismal homeostasis. In bone, GC hormones inhibit expression of the hormone Osteocalcin for poorly understood reasons. Here, we show that in a classical endocrine feedback loop, osteocalcin in return enhanced the biosynthesis of GC as well as mineralocorticoid hormones (adrenal steroidogenesis) in rodents and primates. Conversely, inactivation of osteocalcin signaling in adrenal glands significantly impaired adrenal growth and steroidogenesis in mice. Embryo-made osteocalcin was necessary for normal Sf1 expression in fetal adrenal cells and adrenal cell steroidogenic differentiation and therefore determined the number of steroidogenic cells present in the adrenal glands of adult animals. Embryonic, not postnatal, osteocalcin also governed adrenal growth, adrenal steroidogenesis, blood pressure, electrolyte equilibrium, and the rise in circulating corticosterone levels during the acute stress response in adult offspring. This osteocalcin-dependent regulation of adrenal development and steroidogenesis occurred even in the absence of a functional hypothalamus/pituitary/adrenal axis and explains why osteocalcin administration during pregnancy promoted adrenal growth and steroidogenesis and improved the survival of adrenocorticotropic hormone signaling–deficient animals. This study reveals that a bone-derived embryonic hormone influences lifelong adrenal functions and organismal homeostasis in the mouse.

Authors

Vijay K. Yadav, Julian M. Berger, Parminder Singh, Perumal Nagarajan, Gerard Karsenty

×

Figure 1

Osteocalcin increases circulating GCs and aldosterone in mice and monkeys.

Options: View larger image (or click on image) Download as PowerPoint
Osteocalcin increases circulating GCs and aldosterone in mice and monkey...
(A) Circulating corticosterone levels 2 hours after injection of vehicle or recombinant osteocalcin (Ocn) from different sources (30 ng/g body weight) at 1200 hours in 2-month-old Sv129 male WT mice. (B and C) Circulating corticosterone levels in 2-month-old WT Sv129 males (B) and Sv129 females (C) at different time points after osteocalcin injection. (D) Circulating aldosterone levels 2 hours after vehicle or osteocalcin injection at 1200 hours in 2-month-old male WT Sv129 mice. (E and F) circulating aldosterone levels in Sv129 male (E) and Sv129 female (F) WT mice at different time points after osteocalcin injection. (G–K) Circulating osteocalcin (G), corticosterone (H and J), and aldosterone (I and K) levels in WT, Esposb–/–, and Esposb–/– Ocn+/– mice at 1800 hours. (L–N) Circulating osteocalcin (L), cortisol (M), and aldosterone (N) at different time points after vehicle or human osteocalcin injection at 1000 hours into rhesus monkeys. Statistical analyses were conducted using 1-way ANOVA followed by Tukey’s post hoc test (A–F, G, K, M, and N) or a 2-tailed, unpaired t test (H–J and L). *P < 0.05. n = 6 or more each group for mice; n = 4 or more for rhesus monkeys.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts